MALLORY HENSEL: Open Payments
NPI 1922504299 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 17 payments from 10 companies in 2025. Trend: 2023 $64 · 2024 $413 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $86 |
| SANOFI-AVENTIS U.S. LLC | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| PFIZER INC. | 1 | $26 |
| Exact Sciences Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: REXULTI, WELLBUTRIN, APLENZIN, TZIELD, AIRSUPRA, ZORYVE, NURTEC ODT, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
